Ecopetrol
EC
Coinbase
COIN
MicroStrategy
MSTR
Petroleo Brasileiro SA Petrobras
PBR
MARA Holdings
MARA
US Stock MarketDetailed Quotes
ARQT Arcutis Biotherapeutics
- 14.560
- +0.630+4.52%
Close Jan 2 16:00 ET
- 14.640
- +0.080+0.55%
Post 20:01 ET
1.70BMarket Cap-8.72P/E (TTM)
15.400High14.160Low2.46MVolume14.200Open13.930Pre Close36.33MTurnover2.92%Turnover RatioLossP/E (Static)117.04MShares15.79052wk High10.88P/B1.23BFloat Cap3.11052wk Low--Dividend TTM84.30MShs Float40.880Historical High--Div YieldTTM8.90%Amplitude1.760Historical Low14.763Avg Price1Lot Size
About Arcutis Biotherapeutics Company
Arcutis Biotherapeutics, Inc. engages in the development and commercialization of treatments for dermatological diseases. Its pipeline consists of topical treatments for plaque psoriasis, atopic dermatitis, hand eczema, vitiligo, scalp psoriasis, alopecia areata, and seborrheic dermatitis. The company was founded by Bhaskar Chaudhuri and David W. Osborne in June 2016 and is headquartered in Westlake Village, CA.
Company Profile
SymbolARQT
Company NameArcutis Biotherapeutics
Listing DateJan 31, 2020
Issue Price17.00
Founded2016
CEOMr. Todd Franklin Watanabe
MarketNASDAQ
Employees296
Fiscal Year Ends12-31
Address3027 Townsgate Road,Suite 300
CityWestlake Village
ProvinceCalifornia
CountryUnited States of America
Zip Code91361
Phone1-805-418-5006
Websitehttp://www.arcutis.com
Company Executives
- Name
- Position
- Salary
- Todd Franklin Watanabe
- Director, President and Chief Executive Officer
- 4.94M
- David J. Topper
- Chief Financial Officer and Principal Accounting Officer
- --
- Matthew Richard Moore
- Senior Vice President and Chief Business Officer
- --
- Bethany Dudek
- Chief Technical Officer
- --
- Dr. Patrick Burnett, M.D.,PhD
- Senior Vice President and Chief Medical Officer
- 1.67M
- L. Todd Edwards
- Senior Vice President and Chief Commercial Officer
- 1.66M
- Masaru Matsuda, J.D.
- Senior Vice President and General Counsel
- --
- Patrick J. Heron
- Chairman of the Board
- 181.24K
- Dr. Howard G. Welgus, M.D.
- Director
- 144.24K
- Keith R. Leonard, Jr
- Independent Director
- 146.24K
- Neha Krishnamohan
- Independent Director
- 148.74K
- Halley E. Gilbert
- Independent Director
- 148.74K
- Terrie Curran
- Independent Director
- 148.74K
- Sue-Jean Lin
- Independent Director
- 163.74K
- Dr. Bhaskar Chaudhuri,PhD
- Independent Director
- 153.74K
Trending US Stocks
Fed Rate Cut Beneficiaries Fed Rate Cut Beneficiaries
Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data. Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data.